Pricing Log in Create free account
Saturday 17 October 2026 Export TMO’s income statement to Excel — free account

Thermo Fisher Scientific Inc.

TMO Healthcare Diagnostics & Research

Thermo Fisher Scientific Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.6 billion, up 3.91% from fiscal 2024. In the quarter to June 2026, revenue grew 10.5%, EPS grew 9.35%, free cash flow grew 51.8% and total debt rose 18.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

690.00 6.49 −0.93%
Market cap
$257.5B
P/E
37.1×
Fwd P/E
23.7×
Dividend yield
0.27%
F-score
5/9
Altman Z
3.84
Beneish M
−2.46
Dividend safety
88/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Thermo Fisher Scientific Inc. (TMO) Current ratio

Alert me on Current ratio

Thermo Fisher Scientific Inc.'s current ratio at the end of the quarter to 30 June 2026 was 1.6×, down 0.3× from fiscal 2025 (1.9×). Over the past ten years it has ranged from 1.3× (fiscal 2017) to 2.1× (fiscal 2020); the current reading is higher than 82% of that period. That is below the Diagnostics & Research industry median of 2.0× and below the Healthcare sector median of 3.0×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 1.9× 13.83%
FY2024 1.7× (5.38%)
FY2023 1.8× 18.32%
FY2022 1.5× (0.92%)
FY2021 1.5× (29.75%)
FY2020 2.1× 11.03%
FY2019 1.9× 11.03%
FY2018 1.7× 29.31%
FY2017 1.3× (7.36%)
FY2016 1.4× 4.20%

Quarterly newest first

Period Current ratio Change
Jun 2026 1.6× 1.59%
Mar 2026 1.5× (19.24%)
Dec 2025 1.9× 26.21%
Sep 2025 1.5× (22.53%)
42 more quarters

Against its own ten years

Low 1.3× High 2.1×
Ten-year median 1.7×
Current reading's percentile 82

Current ratio against peers

Company Current ratio
NTRA Natera, Inc. compare 3.0×
A Agilent Technologies, Inc. compare 2.1×
WAT Waters Corporation compare 1.9×
ILMN Illumina, Inc. compare 1.8×
DHR Danaher Corporation compare 1.7×
TMO Thermo Fisher Scientific Inc. 1.6×
IDXX IDEXX Laboratories, Inc. compare 1.2×
MTD Mettler-Toledo International, Inc. compare 1.1×
IQV IQVIA Holdings Inc. compare 0.7×
Diagnostics & Research industry median 2.0×
Healthcare sector median 3.0×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on TMO